United States v. Rocky Wallace

697 F. App'x 375
CourtCourt of Appeals for the Fifth Circuit
DecidedSeptember 14, 2017
Docket16-11784 Summary Calendar
StatusUnpublished

This text of 697 F. App'x 375 (United States v. Rocky Wallace) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Rocky Wallace, 697 F. App'x 375 (5th Cir. 2017).

Opinion

PER CURIAM: *

Rocky Wallace appeals the district court’s judgment revoking his term of supervised release and sentencing him to 18 months of imprisonment and 18 months of supervised release. He argues that the treatment exception set forth in 18 U.S.C. § 3583(d) applies in any case where a su-pervisee fails a drug test, regardless of any other violations committed, and that the district court failed to consider the treatment exception as required by § 3583(d). He also argues that the sentence imposed is substantively unreasonable.

This court generally reviews the district court’s decision to revoke a term of supervised release for an abuse of discretion. United States v. McCormick, 54 F.3d 214, 219 (5th Cir. 1995). This court reviews a revocation sentence under the plainly unreasonable standard in two steps, examining first for procedural error and then for obvious substantive unreasonableness. United States v. Warren, 720 F.3d 321, 326 (5th Cir. 2013). However, issues of statutory interpretation are reviewed de novo. See United States v. Clayton, 613 F.3d 592, 595 (5th Cir. 2010).

We need not clarify whether the district court is required to consider § 3583(d) in cases, like this one, where the revocation of supervised release is based on more than failed drug tests. See United States v. Brooker, 858 F.3d 983, 986 (5th Cir. 2017). Although the district court did not explicitly address the drug treatment exception argument or its reasons for rejecting same prior to revocation, the district court did implicitly consider and explicitly reject that argument. See id. at 986-87. As such, the record does not indicate that the district court failed to consider the drug treatment exception of § 3583(d). See id.

Wallace has failed to show that the district court committed any clear error in imposing his sentence or that the sentence is unreasonable. See United States v. Miller, 634 F.3d 841, 843 (5th Cir. 2011); United States v. Whitelaw, 580 F.3d 256, 260 (5th Cir. 2009); see, e.g., United States v. Kippers, 685 F.3d 491, 500-01 (5th Cir. 2012).

Accordingly, the district court’s judgment is AFFIRMED.

*

Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Whitelaw
580 F.3d 256 (Fifth Circuit, 2009)
United States v. Clayton
613 F.3d 592 (Fifth Circuit, 2010)
United States v. Miller
634 F.3d 841 (Fifth Circuit, 2011)
United States v. Woody Hyatt McCormick Jr.
54 F.3d 214 (Fifth Circuit, 1995)
United States v. Joseph Kippers
685 F.3d 491 (Fifth Circuit, 2012)
United States v. Desrick Warren
720 F.3d 321 (Fifth Circuit, 2013)
United States v. John Brooker
858 F.3d 983 (Fifth Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
697 F. App'x 375, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-rocky-wallace-ca5-2017.